ALFUZOSIN HYDROCHLORIDE (alfuzosin hydrochloride) by Wockhardt is 12. Approved for signs, symptoms of benign prostatic hyperplasia, hypertension. First approved in 2011.
Drug data last refreshed 18h ago
12.1 Mechanism of Action Alfuzosin is a selective antagonist of post-synaptic alpha 1 -adrenoreceptors, which are located in the prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra. 12.2 Pharmacodynamics Alfuzosin exhibits selectivity for alpha adrenergic receptors in the…
Worked on ALFUZOSIN HYDROCHLORIDE at Wockhardt? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.